ロード中...
Conestat alfa for the treatment of angioedema attacks
Recently, multiple C1 inhibitor (C1-INH) replacement products have been approved for the treatment of hereditary angioedema (HAE). This review summarizes HAE and its current treatment modalities and focuses on findings from bench to bedside trials of a new C1-INH replacement, conestat alfa. Conestat...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3132097/ https://ncbi.nlm.nih.gov/pubmed/21753889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S15544 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|